You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

aflibercept

Showing 1 - 25 of 521
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta

Completed
  • Central Serous Chorioretinopathy
  • Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
  • Cairo, Egypt
    Kasr alainy faculty of medicine
May 5, 2023

Chorioretinal Vascular Disease Trial (ABP 938, Aflibercept)

Not yet recruiting
  • Chorioretinal Vascular Disease
  • ABP 938
  • Aflibercept
  • (no location specified)
Jan 20, 2023

Pachychoroid Neovasculopathy Trial (Three monthly injections of intravitreal aflibercept)

Not yet recruiting
  • Pachychoroid Neovasculopathy
  • Three monthly injections of intravitreal aflibercept
  • (no location specified)
Dec 14, 2022

Diabetic Macular Edema Trial in Al Qadisiyah (Phacoemulsification with IVI of aflibercept)

Completed
  • Diabetic Macular Edema
  • Phacoemulsification with IVI of aflibercept
  • Al Qādisīyah, Hawally, Kuwait
    Ahady Hospital
Feb 14, 2023

Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
  • Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
  • Singapore, Singapore
  • +2 more
Nov 14, 2022

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Aflibercept
  • +4 more
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

Aflibercept for Diabetic Macular Edema In Real-life Practice in

Completed
  • Diabetic Macular Edema
  • Aflibercept
  • Athens, Greece
    University of Athens
Dec 27, 2022

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Oct 19, 2023

Diabetic Macular Edema Trial (RC-28E, Aflibercept)

Not yet recruiting
  • Diabetic Macular Edema
  • RC-28E
  • Aflibercept
  • (no location specified)
May 30, 2023

rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Completed
  • Age Related Macular Degeneration
  • Aflibercept
  • Bern, Switzerland
  • +1 more
Nov 28, 2022

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

Completed
  • Age-Related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • Aflibercept (CinnaGen Co, Iran)
  • Aflibercept (Regeneron, USA)
  • Tehran, Iran, Islamic Republic of
    Farabi Hospital
Oct 16, 2022

Data of Intravitreal Aflibercept Injection in Patients of Wet

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, India
    Many Locations
Feb 2, 2023

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)

Not yet recruiting
  • Diabetic Macular Edema
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 6, 2023

Learn More About How Well Aflibercept 8 mg Works in Treating

Not yet recruiting
  • Visual Impairment
  • +2 more
  • Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Australia
  • +5 more
Oct 4, 2023

Intraocular Inflammation and Suspected Endophthalmitis Among

Active, not recruiting
  • Intraocular Inflammation
  • Suspected Endophthalmitis
  • Non Applicable
  • Tarrytown, New York
    Regeneron Research Site
Mar 28, 2023

Polypoidal Choroidal Vasculopathy Trial in Peking (non-interventional)

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • non-interventional
  • Peking, Beijing, China
    Peking Union Medical College Hospital
Nov 28, 2022

Diabetic Macular Edema Trial (FARICIMAB 6 Mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [VABYSMO])

Not yet recruiting
  • Diabetic Macular Edema
  • FARICIMAB 6 Mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [VABYSMO]
  • (no location specified)
Nov 3, 2022

Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

Withdrawn
  • Wet Macular Degeneration
  • Aflibercept 40 MG/ML [Eylea]
  • +2 more
  • Prague, Czechia
    Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022

Diabetic Macular Edema Trial in Ahmedabad (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Not yet recruiting
  • Diabetic Macular Edema
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Ahmedabad, Gujarat, India
    Raghudeep Eye Hospital
Aug 19, 2022